Navigation Links
Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting
Date:5/15/2009

SEATTLE, May 15 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that data from CTI's pivotal phase III EXTEND (PIX301) trial of pixantrone in patients with advanced, relapsed aggressive non-Hodgkin's lymphoma (NHL) will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held from May 29 to June 2, 2009 in Orlando, Florida.

Ruth Pettengell, M.D. of St. George's Hospital, University of London, an investigator on the study, is scheduled to present the data on Monday, June 1, 2009 during the Lymphoma and Plasma Cell Disorders session that will be held from 2:00 PM-6:00 PM Eastern Time. The presentation, abstract #8523, is titled, "Randomized Phase III trial of pixantrone compared with other chemotherapeutic agents for third-line single-agent treatment of relapsed aggressive non-Hodgkin's lymphoma." The abstract is available at www.asco.org.

CTI expects to complete the submission of a New Drug Application ("NDA") for pixantrone this quarter and will request priority review which if granted could lead to an approval decision from the U.S. Food and Drug Administration ("FDA") during the fourth quarter of 2009.

About Pixantrone

Pixantrone (BBR 2778), is a novel major groove binder with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines are the cornerstone therapeutic for the treatment of lymphoma, leukemia, and breast cancer. Although they are sufficiently effective to be used as first-line (initial) treatment, they cause cumulative heart damage that may result in congestive heart failure many years later. As a result, there is a lifetime limit of anthracycline doses and most patients who previously have been treated with an anthracycline are not able to r
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkins Lymphoma
2. Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
3. Pixantrone Increases Progression-Free Survival by 81% Compared to Standard Chemotherapeutic Agents in Phase III Relapsed Aggressive non-Hodgkins Lymphoma Trial
4. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
5. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
6. Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
7. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
8. Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis
9. Pixantrone Shows Activity in a Preclinical Study of Experimental Autoimmune Myasthenia Gravis (EAMG)
10. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... -- The new 13-valent pneumococcal conjugate vaccine (PCV13) appears ... prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), ... Vaccine. The U.S. Food and Drug Administration ... series of trials. These trials found that PCV13, which ... the previously used PCV7, did not increase the risk ...
(Date:5/22/2013)... , May 22, 2013 ... is investigating claims on behalf of investors of Intuitive ... ISRG ) (CUSIP: 46120E602) who purchased Intuitive Surgical ... 2013 (the "Class Period"). Such investors are advised to ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ...
(Date:5/22/2013)... ORLEANS , May 22, 2013 ... for commercially-insured patients with Type 2 diabetes, while ... to improve health outcomes and can lead to ... presented at the International Society for Pharmacoeconomics and ... The two studies, sponsored by Valeritas, makers ...
Breaking Medicine Technology:Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6
(Date:5/22/2013)... (PRWEB) May 22, 2013 TWITTER: @the_USO ... Family Tour together, heading to 8 countries in the next 6 ... Street, Cookie Monster and Members of Congress came together to show ... assembled 2,000 USO Care Packages for distribution to our ... celebrate the five-year partnership of Sesame Street and the USO as ...
(Date:5/22/2013)... Belleville, IL (PRWEB) May 22, 2013 ... of Veterans’ Appeals (BVA) in fiscal year 2012, with ... find themselves waiting longer for a decision as the ... to Allsup, which provides veterans disability appeal ... Department of Veterans Affairs. , Although the BVA received ...
(Date:5/22/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- People who ... to attempt suicide, whether or not they also suffer ... new study. "Clinicians who are seeing patients with ... increased risk of suicide," said study co-author Mark Ilgen, ... and Evaluation Center in Ann Arbor, Mich. "Although ...
(Date:5/22/2013)... Bodybuilding.com is giving back to ... 2013) Bodybuilding.com will be donating $1 from EVERY purchase made ... “We are extremely grateful for the men and women who ... DeLuca, CEO and founder of Bodybuilding.com. “It’s an honor to ... much. Hire Heroes USA is an amazing organization that supports ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Today, Zane ... Alabama Health Insurance Exchange . Zane Benefits, which provides ... benefits, is the leader in defined contribution plans ... to Zane Benefits’ website, beginning in 2014 as part ... for individuals and small businesses will become available through ...
Breaking Medicine News(10 mins):Health News:The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC 2Health News:The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC 3Health News:The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC 4Health News:The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC 5Health News:Veterans Disability Appeals See Fewer Decisions in FY2012, Reports Allsup 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3
... researchers find reducing air particulates for just 2 days ... News) -- A breath of filtered indoor air may ... Using high efficiency particle air (HEPA) filters for just ... health in healthy, nonsmoking elderly individuals, according to a ...
... ,Barack Will Change America, WASHINGTON, Feb. 15 ... endorsed Sen. Barack Obama for,president today, calling him ... best strategy to lead the country to a ... Employees International Union endorsed Obama to,achieve economic justice, ...
... WI, February 11, 2008 -- In forests of the ... dissolved forms of sulfur and nitrogen in precipitation. In ... are released to groundwater and streams over a short ... of sulfate and nitrate in snowmelt can cause episodic ...
... reported more interpersonal conflicts had more health problems, study found ... that getting along with others is more than a key ... for your health. , Researchers who studied a survey ... along with their relatives, friends and neighbors were less likely ...
... Novo Nordisk A/S has,filed its Annual Report 2007 ... US Securities and Exchange Commission (SEC), incorporating by reference,the ... available at the,SEC,s website, http://www.sec.gov, as well ... ADR holders may receive a hard copy of the ...
... for $10,000 and Silver Screen Debut, ROSWELL, Ga., ... on the silver screen and contend for a chance ... hosted by DentaBurst brand,freshening teeth cleaners., The contest ... to March 30 to submit a short video (no ...
Cached Medicine News:Health News:HEPA Filters May Improve Cardiovascular Health 2Health News:SEIU Members Endorse Sen. Barack Obama 2Health News:Melting snow provides clues for acidification 2Health News:Unlike Fine Wine, Crabby People Don't Age Well 2Health News:Unlike Fine Wine, Crabby People Don't Age Well 3Health News:DentaBurst(TM) Freshening Teeth Cleaners Launches Outshine Everyone Video Contest 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: